Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 351

1.

Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study.

Shiroyama T, Nagatomo I, Koyama S, Hirata H, Nishida S, Miyake K, Fukushima K, Shirai Y, Mitsui Y, Takata S, Masuhiro K, Yaga M, Iwahori K, Takeda Y, Kida H, Kumanogoh A.

Sci Rep. 2019 Feb 21;9(1):2447. doi: 10.1038/s41598-019-39120-6.

2.

Bronchial epithelial cells produce CXCL1 in response to LPS and TNFα: A potential role in the pathogenesis of COPD.

Inui T, Watanabe M, Nakamoto K, Sada M, Hirata A, Nakamura M, Honda K, Ogawa Y, Takata S, Yokoyama T, Saraya T, Kurai D, Wada H, Ishii H, Takizawa H.

Exp Lung Res. 2018 Sep;44(7):323-331. doi: 10.1080/01902148.2018.1520936. Epub 2019 Jan 24.

PMID:
30676127
3.

Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancer.

Aiso T, Ohtsuka K, Ueda M, Karita S, Yokoyama T, Takata S, Matsuki N, Kondo H, Takizawa H, Okada AA, Watanabe T, Ohnishi H.

Oncol Lett. 2018 Nov;16(5):6643-6651. doi: 10.3892/ol.2018.9464. Epub 2018 Sep 20.

4.

Multi-Sip Time⁻Intensity Evaluation of Retronasal Aroma after Swallowing Oolong Tea Beverage.

Gotow N, Omata T, Uchida M, Matsuzaki N, Takata S, Hagiwara I, Kobayakawa T.

Foods. 2018 Oct 25;7(11). pii: E177. doi: 10.3390/foods7110177.

5.

MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity.

Sekiguchi N, Kubo C, Takahashi A, Muraoka K, Takeiri A, Ito S, Yano M, Mimoto F, Maeda A, Iwayanagi Y, Wakabayashi T, Takata S, Murao N, Chiba S, Ishigai M.

MAbs. 2018 Nov-Dec;10(8):1168-1181. doi: 10.1080/19420862.2018.1518888. Epub 2018 Oct 1.

PMID:
30199322
6.

Significant Association Between Coronary Artery Low-Attenuation Plaque Volume and Apnea-Hypopnea Index, But Not Muscle Sympathetic Nerve Activity, in Patients With Obstructive Sleep Apnea Syndrome.

Hamaoka T, Murai H, Kaneko S, Usui S, Inoue O, Sugimoto H, Mukai Y, Okabe Y, Tokuhisa H, Takashima S, Kato T, Furusho H, Kashiwaya S, Sugiyama Y, Nakatsumi Y, Takata S, Takamura M.

Circ J. 2018 Oct 25;82(11):2852-2860. doi: 10.1253/circj.CJ-18-0237. Epub 2018 Sep 7.

7.

Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma with G719S, S768I, and T790M Mutations.

Nasu S, Shiroyama T, Morita S, Takata S, Takada H, Masuhiro K, Tanaka A, Morishita N, Suzuki H, Okamoto N, Hirashima T.

Intern Med. 2018 Dec 15;57(24):3643-3645. doi: 10.2169/internalmedicine.0923-18. Epub 2018 Aug 24.

8.

Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents.

Takata S, Koh G, Han Y, Yoshida H, Shiroyama T, Takada H, Masuhiro K, Nasu S, Morita S, Tanaka A, Hashimoto S, Uriu K, Suzuki H, Tamura Y, Okamoto N, Nagai T, Hirashima T.

J Infect Chemother. 2019 Jan;25(1):54-58. doi: 10.1016/j.jiac.2018.06.016. Epub 2018 Jul 25.

9.

Transformation to small cell lung cancer after first-line afatinib treatment.

Shiroyama T, Nasu S, Tanaka A, Takata S, Masuhiro K, Takada H, Morita S, Morishita N, Suzuki H, Okamoto N, Kawahara K, Hirashima T.

Respir Med Case Rep. 2018 Mar 1;23:188-190. doi: 10.1016/j.rmcr.2018.02.011. eCollection 2018.

10.

Evaluation of anionic surfactants effects on the skin barrier function based on skin permeability.

Okasaka M, Kubota K, Yamasaki E, Yang J, Takata S.

Pharm Dev Technol. 2019 Jan;24(1):99-104. doi: 10.1080/10837450.2018.1425885. Epub 2018 Jan 23.

PMID:
29323614
11.

Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.

Inoue Y, Shimazawa M, Nakamura S, Takata S, Hashimoto Y, Izawa H, Masuda T, Tsuruma K, Sakaue T, Nakayama H, Higashiyama S, Hara H.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):174-185. doi: 10.1161/ATVBAHA.117.310337. Epub 2017 Nov 30.

PMID:
29191924
12.

The promotion of nephropathy by Porphyromonas gingivalis lipopolysaccharide via toll-like receptors.

Kajiwara K, Takata S, To TT, Takara K, Hatakeyama Y, Tamaoki S, Darveau RP, Ishikawa H, Sawa Y.

Diabetol Metab Syndr. 2017 Sep 22;9:73. doi: 10.1186/s13098-017-0271-8. eCollection 2017.

13.

Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study.

Shiroyama T, Tamiya M, Minami S, Takata S, Masuhiro K, Futami-Nishijima Y, Uenami T, Mori M, Koba T, Matsuki T, Takimoto T, Suzuki H, Okamoto N, Komuta K, Hirashima T, Kumanogoh A, Kijima T.

Cancer Chemother Pharmacol. 2017 Sep;80(3):461-467. doi: 10.1007/s00280-017-3385-7. Epub 2017 Jul 7.

PMID:
28688052
14.

Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Developed in a Patient with Progressive Muscular Dystrophy: A Case Report and Review of the Literature.

Miyagi R, Nishisho T, Takata S, Shimatani Y, Toki S, Sairyo K.

Case Rep Orthop. 2017;2017:3025084. doi: 10.1155/2017/3025084. Epub 2017 May 29.

15.

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.

Misumi Y, Okamoto H, Sasaki J, Masuda N, Ishii M, Shimokawa T, Hosomi Y, Okuma Y, Nagamata M, Ogura T, Kato T, Sata M, Otani S, Takakura A, Minato K, Miura Y, Yokoyama T, Takata S, Naoki K, Watanabe K.

BMC Cancer. 2017 May 26;17(1):377. doi: 10.1186/s12885-017-3353-y.

16.

The Evaluation of the Sputum Antigen Kit in the Diagnosis of Pneumococcal Pneumonia.

Ikegame S, Nakano T, Otsuka J, Yoshimi M, Matsuo T, Kubota M, Tao Y, Takata S.

Intern Med. 2017;56(10):1141-1146. doi: 10.2169/internalmedicine.56.7935. Epub 2017 May 15.

17.

Impact of Audio-Visual Asynchrony on Lip-Reading Effects -Neuromagnetic and Psychophysical Study.

Kawase T, Yahata I, Kanno A, Sakamoto S, Takanashi Y, Takata S, Nakasato N, Kawashima R, Katori Y.

PLoS One. 2016 Dec 28;11(12):e0168740. doi: 10.1371/journal.pone.0168740. eCollection 2016.

18.

Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis.

Wakamatsu K, Nagata N, Kumazoe H, Oda K, Ishimoto H, Yoshimi M, Takata S, Hamada M, Koreeda Y, Takakura K, Ishizu M, Hara M, Ise S, Izumi M, Akasaki T, Maki S, Kawabata M, Mukae H, Kawasaki M.

Respir Investig. 2017 Jan;55(1):16-23. doi: 10.1016/j.resinv.2016.09.003. Epub 2016 Nov 9.

PMID:
28012488
19.

Clinical significance of the "galaxy sign" in patients with pulmonary sarcoidosis in a Japanese single-center cohort.

Koide T, Saraya T, Tsukahara Y, Bonella F, Börner E, Ishida M, Ogawa Y, Hirukawa I, Oda M, Shimoda M, Ohkuma K, Fujiwara M, Takata S, Yokoyama T, Kurai D, Ishii H, Goto H, Takizawa H.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 7;33(3):247-252.

PMID:
27758990
20.

Synthesis of Fluorescent Gelators and Direct Observation of Gelation with a Fluorescence Microscope.

Hanabusa K, Ueda T, Takata S, Suzuki M.

Chemistry. 2016 Nov 14;22(47):16939-16949. doi: 10.1002/chem.201603295. Epub 2016 Oct 10.

PMID:
27723140

Supplemental Content

Loading ...
Support Center